. 2018;31(101):25.

River blindness: reducing the prevalence of clinical disease

Affiliations

¹ Senior Technical Adviser: Task Force for Global Health, Atlanta, USA.
² Senior Advisor for Neglected Tropical Diseases: CBM, Nairobi, Kenya.
³ Senior Scientist: Institute for Laboratory Animal Science, University of Zurich, Switzerland.
⁴ Director: Mectizan Donation Program, Georgia, USA.

Charles Mackenzie et al. Community Eye Health. 2018.

. 2018;31(101):25.

¹ Senior Technical Adviser: Task Force for Global Health, Atlanta, USA.
² Senior Advisor for Neglected Tropical Diseases: CBM, Nairobi, Kenya.
³ Senior Scientist: Institute for Laboratory Animal Science, University of Zurich, Switzerland.
⁴ Director: Mectizan Donation Program, Georgia, USA.

No abstract available

Figures

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions.
Colebunders R, Stolk WA, Siewe Fodjo JN, Mackenzie CD, Hopkins A. Colebunders R, et al. Infect Dis Poverty. 2019 Oct 3;8(1):83. doi: 10.1186/s40249-019-0593-x. Infect Dis Poverty. 2019. PMID: 31578157 Free PMC article.

1. Cupp EW, Mackenzie CD, Unnasch T. The Importance of ivermectin to human onchocerciasis: past, present, and the future. Research and Reports in Tropica Medicine. 2011, 2:81–92. - PMC - PubMed
1. Samuel A, Belay T, et al. Impact of Six Years Community Directed Treatment with Ivermectin in the Control of Onchocerciasis, Western Ethiopia. 2016. PLOS One. - PMC - PubMed
1. World Health Organization 2018. River blindness: shifting from prevention to surveillance and elimination.